1015. Deputy Stephen S. Donnelly asked the Minister for Health the pharmaceutical products used by the HSE exclusively available from UK manufacturers; the annual cost of these products; the risks to ongoing availability in the case of no agreement being reached in Brexit negotiations; if contingency planning is in place for these products; the expected timeline for accreditation of these products in this scenario; and if he will make a statement on the matter. [26556/17]

Summary

1015. Deputy Stephen S. Donnelly asked the Minister for Health the pharmaceutical products used by the HSE exclusively available from UK manufacturers; the annual cost of these products; the risks to ongoing availability in the case of no agreement being reached in Brexit negotiations; if contingency planning is in place for these products; the expected timeline for accreditation of these products in this scenario; and if he will make a statement on the matter. [26556/17]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 20 June 2017

   Medicinal Products Prices

   1015. Deputy Stephen S. Donnelly asked the Minister for Health the pharmaceutical products used by the HSE exclusively available from UK manufacturers; the annual cost of these products; the risks to ongoing availability in the case of no agreement being reached in Brexit negotiations; if contingency planning is in place for these products; the expected timeline for accreditation of these products in this scenario; and if he will make a statement on the matter. [26556/17]

   Source: written

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products Prices

  xml · EN · 20 June 2017

  ViewDownloadOpen at official source

Sponsors

• Donnelly, Stephen. · Asking member
• Health · Health · Addressed to

Related records

No cross-record relationships stored yet.